Wealth Enhancement Advisory Services, LLC Iovance Biotherapeutics, Inc. Transaction History
Wealth Enhancement Advisory Services, LLC
- $49.5 Billion
- Q4 2024
A detailed history of Wealth Enhancement Advisory Services, LLC transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Wealth Enhancement Advisory Services, LLC holds 18,738 shares of IOVA stock, worth $66,707. This represents 0.0% of its overall portfolio holdings.
Number of Shares
18,738
Previous 24,409
23.23%
Holding current value
$66,707
Previous $180,000
23.33%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding IOVA
# of Institutions
342Shares Held
247MCall Options Held
2.51MPut Options Held
3.5M-
Vanguard Group Inc Valley Forge, PA27.5MShares$98 Million0.0% of portfolio
-
Mhr Fund Management LLC New York, NY24.4MShares$86.9 Million24.02% of portfolio
-
Perceptive Advisors LLC New York, NY22.1MShares$78.7 Million5.46% of portfolio
-
Black Rock Inc. New York, NY21.2MShares$75.6 Million0.0% of portfolio
-
State Street Corp Boston, MA12.2MShares$43.6 Million0.0% of portfolio
About IOVANCE BIOTHERAPEUTICS, INC.
- Ticker IOVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 157,800,992
- Market Cap $562M
- Description
- Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...